10-year trajectories of depressive symptoms and risk of dementia: a population-based study

Published on Jul 1, 2016in The Lancet Psychiatry18.33
· DOI :10.1016/S2215-0366(16)00097-3
Saira Saeed Mirza14
Estimated H-index: 14
(EUR: Erasmus University Rotterdam),
Frank J. Wolters12
Estimated H-index: 12
(EUR: Erasmus University Rotterdam)
+ 4 AuthorsM. Arfan Ikram71
Estimated H-index: 71
(EUR: Erasmus University Rotterdam)
Summary Background Late-life depressive symptoms have been extensively studied for their relationship with incident dementia, but have been typically assessed at a single timepoint. Such an approach neglects the course of depression, which, given its remitting and relapsing nature, might provide further insights into the complex association of depression with dementia. We therefore repeatedly measured depressive symptoms in a population of adults over a decade to study the subsequent risk of dementia. Methods Our study was embedded in the Rotterdam Study, a population-based study of adults aged 55 years or older in Rotterdam (Netherlands), ongoing since 1990. The cohort is monitored continuously for major events by data linkage between the study database and general practitioners. We examined a cohort of participants who were free from dementia, but had data for depressive symptoms from at least one examination round in 1993–95, 1997–99, or 2002–04. We assessed depressive symptoms with the validated Dutch version of the Center for Epidemiology Depression Scale (CES-D) and the Hospital Anxiety and Depression Scale-Depression. We used these data to identify 11-year trajectories of depressive symptoms by latent class trajectory modelling. We screened participants for dementia at each examination round and followed up participants for 10 years for incident dementia by latent trajectory from the third examination round to 2014. We calculated hazard ratios (HR) for dementia by assigned trajectory using two Cox proportional hazards models (model 1 adjusted for age and sex only, and model 2 adjusted additionally for APOE ɛ4 carrier status, educational level, body-mass index, smoking, alcohol consumption, cognitive score, use of antidepressants, and prevalent disease status at baseline). We repeated the analyses censoring for incident stroke, restricting to Alzheimer's disease as an outcome, and accounting for mortality as a competing risk for dementia. Findings From 1993–2004, we obtained data for depressive symptoms from at least one examination round for 3325 participants (median age: 74·88 years [IQR 70·62–80·06], 1995 [60%] women). We identified five trajectories of depressive symptoms in these 3325 individuals, characterised by maintained low CES-D scores (low; 2441 [73%]); moderately high starting scores but then remitting (decreasing; 369 [11%]); low starting scores, increasing, then remitting (remitting; 170 [5%]); low starting scores that steadily increased (increasing; 255 [8%]); and maintained high scores (high; 90 [3%]). During 26 330 person-years, 434 participants developed incident dementia. Only the trajectory with increasing depressive symptoms was associated with a higher risk of dementia compared with the low depressive symptom trajectory, using model 2 (HR 1·42, 95% CI 1·05–1·94; p=0·024). Additionally, only the increasing trajectory was associated with a higher risk of dementia compared with the low trajectory after censoring for incident stroke (1·58, 1·15–2·16; p=0·0041), restricting to Alzheimer's disease as an outcome (1·44, 1·03–2·02; p=0·034), and accounting for mortality as a competing risk (1·45, 1·06–1·97; p=0·019). Interpretation Risk of dementia differed with different courses of depression, which could not be captured by a single assessment of depressive symptoms. The higher risk of dementia only in the increasing trajectory suggests depression might be a prodrome of dementia. Funding Erasmus Medical Center; ZonMw; the Netherlands Ministry of Education Culture and Science; and the Netherlands Ministry for Health, Welfare and Sports.
  • References (33)
  • Citations (49)
#1Allison R. Kaup (UCSF: University of California, San Francisco)H-Index: 12
#2Amy L. Byers (UCSF: University of California, San Francisco)H-Index: 25
Last.Kristine YaffeH-Index: 113
view all 9 authors...
#1Julie A. Graziane (University of Pittsburgh)H-Index: 1
#2Joanne C. Beer (University of Pittsburgh)H-Index: 2
Last.Mary Ganguli (University of Pittsburgh)H-Index: 61
view all 5 authors...
#1Renée F.A.G. de Bruijn (Erasmus University Medical Center)H-Index: 21
#2Michiel J Bos (Erasmus University Medical Center)H-Index: 1
Last.M. Arfan Ikram (Erasmus University Medical Center)H-Index: 71
view all 7 authors...
#1João R. Araújo (Pasteur Institute)H-Index: 16
#2Fátima Martel (University of Porto)H-Index: 27
Last.Elisa Keating (CUA: The Catholic University of America)H-Index: 16
view all 5 authors...
#1Shelly L. Gray (UW: University of Washington)H-Index: 32
#2Melissa L. Anderson (Group Health Research Institute)H-Index: 39
Last.Eric B. Larson (Group Health Research Institute)H-Index: 108
view all 9 authors...
Cited By49
#1Isabelle Bos (UM: Maastricht University)H-Index: 3
#2Stephanie J.B. Vos (UM: Maastricht University)H-Index: 13
Last.Anne M. Fagan (WashU: Washington University in St. Louis)H-Index: 69
view all 10 authors...
#1Thach Duc Tran (Monash University)H-Index: 16
#2Karin Hammarberg (Monash University)H-Index: 18
Last.Helen BrownH-Index: 1
view all 10 authors...
#1Alejandro de la Torre-Luque (UAM: Autonomous University of Madrid)H-Index: 6
#2Javier de la Fuente (UAM: Autonomous University of Madrid)H-Index: 2
Last.José Luis Ayuso-Mateos (UAM: Autonomous University of Madrid)H-Index: 43
view all 6 authors...
View next paperLate-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies